Solbec has been undervalued for a while now. Cancer and psoriasis both successful in phase I trials and the company is moving towards phase II in both these multi-billion dollar markets. The drug has been shown to stimulate immunity towards cancer and preclinical studies continue in this area with results expected in a month or two. This only adds to the excitement building towards Coramsine. There is also growing interest from overseas and one would expect news of a partnership agreement with a big pharam sooner rather than later.
- Forums
- ASX - By Stock
- SBP
- solbec now 12cents
SBP
solbec pharmaceuticals limited
solbec now 12cents, page-2
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)